Abstract
To evaluate the association of plasma osteoprotegerin (OPG) to hospitalisation for ischaemic heart disease (IHD), ischaemic stroke and all-cause mortality, and the effect of combining plasma OPG and high-sensitivity C-reactive protein (hsCRP).
Originalsprog | Engelsk |
---|---|
Tidsskrift | Heart |
Vol/bind | 99 |
Udgave nummer | 2 |
Sider (fra-til) | 106-10 |
Antal sider | 5 |
ISSN | 1355-6037 |
DOI | |
Status | Udgivet - 2013 |